BioForce Nanosciences Delays Annual 10-K Filing

BioForce Nanosciences Holdings ( (BFNH) ) has released a notification of late filing.

BioForce Nanosciences Holdings, Inc. has filed a Form 12b-25, notifying investors of a delay in submitting its Form 10-K (Yearly Report) for the fiscal year ended December 31, 2025. The filing extension relates specifically to the company’s annual report with the U.S. Securities and Exchange Commission.

The company explains that it has encountered a delay in assembling the information required for inclusion in the Form 10-K (Yearly Report). No additional issues such as auditor changes, internal control problems, or special committee reviews are mentioned in the notification.

BioForce Nanosciences states that it expects to file the Form 10-K (Yearly Report) within 15 calendar days after the original due date. This is consistent with the standard grace period allowed under SEC rules for late annual filings when a Form 12b-25 is submitted.

Management indicates that it does not anticipate any significant change in results of operations compared with the same period in the prior fiscal year. As with all forward-looking statements, this expectation could be affected by subsequent adjustments once the full financial statements and disclosures are finalized.

The company affirms that all other periodic reports required over the past 12 months have been filed, underscoring an effort to remain in overall reporting compliance. The notification is signed on March 31, 2026, by Richard Kaiser, Chief Financial Officer, signaling executive responsibility for the delayed filing and the planned completion timeline.

More about BioForce Nanosciences Holdings

Average Trading Volume: 2,110

Technical Sentiment Signal: Strong Sell

Current Market Cap: $16.38M

For detailed information about BFNH stock, go to TipRanks’ Stock Analysis page.